2014, 12 or 30 months of dual antiplatelet therapy after drug-eluting stents PCI, NEJM
2012, Percutaneous Coronary Intervention (PCI) vs CABG in Patients with Diabetes and multivessel CAD
2018, Culprit lesion vs multivessel PCI in ACS with cardiogenic shock, NEJM
2013, Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events, NEJM
2007, PCI + medical therapy vs medical therapy only in stable coronary artery disease, NEJM Courage Trial Summary COURAGE was a randomized, open label, multicenter (50 centers in US & Canada), co-industry sponsored, clinical trial which tested the hypothesis that PCI with optimal medical therapy (OMT) is superior to OMT alone in reducing primary outcome..